1. Academic Validation
  2. Disordered breathing in a Pitt-Hopkins syndrome model involves Phox2b-expressing parafacial neurons and aberrant Nav1.8 expression

Disordered breathing in a Pitt-Hopkins syndrome model involves Phox2b-expressing parafacial neurons and aberrant Nav1.8 expression

  • Nat Commun. 2021 Oct 13;12(1):5962. doi: 10.1038/s41467-021-26263-2.
C M Cleary 1 S James 1 B J Maher 2 3 4 D K Mulkey 5
Affiliations

Affiliations

  • 1 Department of Physiology and Neurobiology, University of Connecticut, Storrs, CT, USA.
  • 2 Lieber Institute for Brain Development, Johns Hopkins Medical Campus, Baltimore, MD, 21205, USA.
  • 3 Department of Psychiatry and Behavioral Sciences, Johns Hopkins School of Medicine, Baltimore, MD, 21287, USA.
  • 4 Department of Neuroscience, Johns Hopkins School of Medicine, Baltimore, MD, 21205, USA.
  • 5 Department of Physiology and Neurobiology, University of Connecticut, Storrs, CT, USA. daniel.mulkey@uconn.edu.
Abstract

Pitt-Hopkins syndrome (PTHS) is a rare autism spectrum-like disorder characterized by intellectual disability, developmental delays, and breathing problems involving episodes of hyperventilation followed by apnea. PTHS is caused by functional haploinsufficiency of the gene encoding transcription factor 4 (Tcf4). Despite the severity of this disease, mechanisms contributing to PTHS behavioral abnormalities are not well understood. Here, we show that a Tcf4 truncation (Tcf4tr/+) mouse model of PTHS exhibits breathing problems similar to PTHS patients. This behavioral deficit is associated with selective loss of putative expiratory parafacial neurons and compromised function of neurons in the retrotrapezoid nucleus that regulate breathing in response to tissue CO2/H+. We also show that central Nav1.8 channels can be targeted pharmacologically to improve respiratory function at the cellular and behavioral levels in Tcf4tr/+ mice, thus establishing Nav1.8 as a high priority target with therapeutic potential in PTHS.

Figures
Products